• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价戈登氏菌 DSM 27213 中参与尿石素脱氢的电子传递辅助因子介导的酶系统。

Evaluation of electron-transferring cofactor mediating enzyme systems involved in urolithin dehydroxylation in Gordonibacter urolithinfaciens DSM 27213.

机构信息

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kitashirakawaoiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.

Corporate Research Center, Innovation and Business Development Headquarters, Arai Plant, Daicel Corporation, 1-1 Shinko-cho, Myoko-shi, Niigata 944-8550, Japan.

出版信息

J Biosci Bioeng. 2020 May;129(5):552-557. doi: 10.1016/j.jbiosc.2019.11.014. Epub 2020 Jan 23.

DOI:10.1016/j.jbiosc.2019.11.014
PMID:31983661
Abstract

The gut bacterium Gordonibacter urolithinfaciens DSM 27213 metabolizes ellagic acid into three polyphenol compounds, namely, urolithin M5, urolithin M6, and urolithin C, which are collectively called urolithin. The key reactions of this metabolic pathway are the dehydroxylation of the phenolic hydroxy group, i.e., conversion of urolithin M5 to urolithin M6, and successive conversion of urolithin M6 to urolithin C. By testing the effects of various electron-transferring compounds on the dehydroxylation reactions, methylviologen was found to effectively support the dehydroxylation catalyzed by the cell free extracts. The urolithin dehydroxylating enzymes were found in the soluble fraction of the cell free extracts. The urolithin dehydroxylation was found to be coupled with reduction of dicationic methylviologen to a cation radical form catalyzed by enzymes with hydrogen as an electron donor, which was also found with the soluble fraction. Further investigation of the reaction in the presence of natural cofactors with or without methylviologen and hydrogen revealed the involvement of NADPH and FAD in the electron transportation systems of the urolithin dehydroxylation.

摘要

肠道细菌戈登氏菌(Gordonibacter urolithinfaciens)DSM 27213 将鞣花酸代谢为三种多酚化合物,即尿石素 M5、尿石素 M6 和尿石素 C,它们统称为尿石素。该代谢途径的关键反应是酚羟基的去羟基化,即尿石素 M5 转化为尿石素 M6,以及尿石素 M6 连续转化为尿石素 C。通过测试各种电子转移化合物对去羟基化反应的影响,发现甲紫精可有效支持无细胞提取物催化的去羟基化。尿石素去羟化酶存在于无细胞提取物的可溶性部分中。发现尿石素去羟化与二价阳离子甲紫精的还原偶联,由酶以氢作为电子供体催化,在可溶性部分也发现了这种情况。在存在或不存在甲紫精和氢的天然辅因子的情况下进一步研究反应,揭示了 NADPH 和 FAD 参与尿石素去羟化的电子传递系统。

相似文献

1
Evaluation of electron-transferring cofactor mediating enzyme systems involved in urolithin dehydroxylation in Gordonibacter urolithinfaciens DSM 27213.评价戈登氏菌 DSM 27213 中参与尿石素脱氢的电子传递辅助因子介导的酶系统。
J Biosci Bioeng. 2020 May;129(5):552-557. doi: 10.1016/j.jbiosc.2019.11.014. Epub 2020 Jan 23.
2
Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species.两种人体肠道戈登氏菌将鞣花酸转化为尿石素能力的描述
Food Funct. 2014 Aug;5(8):1779-84. doi: 10.1039/c4fo00092g.
3
Metabolism of different dietary phenolic compounds by the urolithin-producing human-gut bacteria Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens.产尿石素的人体肠道细菌戈登氏尿石杆菌和异尿石素埃拉格杆菌对不同膳食酚类化合物的代谢。
Food Funct. 2020 Aug 1;11(8):7012-7022. doi: 10.1039/d0fo01649g. Epub 2020 Jul 27.
4
Oral supplementation of Gordonibacter urolithinfaciens promotes ellagic acid metabolism and urolithin bioavailability in mice.口服补充戈登氏菌(Gordonibacter urolithinfaciens)可促进小鼠体内鞣花酸代谢和鞣花酸生物利用度。
Food Chem. 2024 Mar 30;437(Pt 2):137953. doi: 10.1016/j.foodchem.2023.137953. Epub 2023 Nov 7.
5
Complete Genome Sequence of the New Urolithin-Producing Bacterium DSM 27213.新型产尿石素细菌DSM 27213的全基因组序列
Genome Announc. 2017 Dec 14;5(50):e01120-17. doi: 10.1128/genomeA.01120-17.
6
Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation.鞣花酸与肠道微生物群代谢产物尿石素A:关于其来源、代谢分布、健康益处及生物转化的综述
Crit Rev Food Sci Nutr. 2023;63(24):6900-6922. doi: 10.1080/10408398.2022.2036693. Epub 2022 Feb 10.
7
Isolation of Human Intestinal Bacteria Capable of Producing the Bioactive Metabolite Isourolithin A from Ellagic Acid.从鞣花酸中分离出能够产生生物活性代谢物异尿石素A的人肠道细菌。
Front Microbiol. 2017 Aug 7;8:1521. doi: 10.3389/fmicb.2017.01521. eCollection 2017.
8
Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut.戈登氏尿道石菌,一种从人类肠道中分离出的能够产生尿石素的细菌。
Int J Syst Evol Microbiol. 2014 Jul;64(Pt 7):2346-2352. doi: 10.1099/ijs.0.055095-0. Epub 2014 Apr 17.
9
The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism.与超重和肥胖相关的人体肠道微生物生态决定了鞣花酸的代谢。
Food Funct. 2016 Apr;7(4):1769-74. doi: 10.1039/c5fo01100k.
10
Gastrointestinal Simulation Model TWIN-SHIME Shows Differences between Human Urolithin-Metabotypes in Gut Microbiota Composition, Pomegranate Polyphenol Metabolism, and Transport along the Intestinal Tract.胃肠道模拟模型 TWIN-SHIME 显示人类尿石素代谢亚型在肠道微生物组成、石榴多酚代谢和沿肠道转运方面的差异。
J Agric Food Chem. 2017 Jul 12;65(27):5480-5493. doi: 10.1021/acs.jafc.7b02049. Epub 2017 Jun 28.

引用本文的文献

1
The relationship between gastric microbiome features and responses to neoadjuvant chemotherapy in gastric cancer.胃癌中胃微生物群特征与新辅助化疗反应之间的关系。
Front Microbiol. 2024 Apr 17;15:1357261. doi: 10.3389/fmicb.2024.1357261. eCollection 2024.
2
Urolithins: A Prospective Alternative against Brain Aging.尿石素:一种对抗大脑衰老的潜在选择。
Nutrients. 2023 Sep 6;15(18):3884. doi: 10.3390/nu15183884.
3
A Novel FUA329 Isolated from Human Breast Milk Capable of Producing Urolithin A from Ellagic Acid.从人母乳中分离出的一种新型FUA329,能够从鞣花酸产生尿石素A。
Foods. 2022 Oct 20;11(20):3280. doi: 10.3390/foods11203280.
4
Supplementation of BC2000 and Ellagic Acid Inhibits High-Fat-Induced Hypercholesterolemia by Promoting Liver Primary Bile Acid Biosynthesis and Intestinal Cholesterol Excretion in Mice.补充BC2000和鞣花酸通过促进小鼠肝脏初级胆汁酸生物合成和肠道胆固醇排泄来抑制高脂诱导的高胆固醇血症。
Microorganisms. 2023 Jan 19;11(2):264. doi: 10.3390/microorganisms11020264.
5
Isolation and characterization of a novel human intestinal FUA027 capable of producing urolithin A from ellagic acid.一种能够从鞣花酸产生尿石素A的新型人类肠道FUA027的分离与鉴定。
Front Nutr. 2022 Nov 9;9:1039697. doi: 10.3389/fnut.2022.1039697. eCollection 2022.
6
Rapid Profiling of Metabolites Combined with Network Pharmacology to Explore the Potential Mechanism of L. against Thrombocytopenia.代谢物快速分析结合网络药理学探索L.治疗血小板减少症的潜在机制
Metabolites. 2022 Nov 5;12(11):1074. doi: 10.3390/metabo12111074.
7
Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment.鞣花酸:一种用于轻度认知障碍药物研发的膳食来源酚类化合物。
Front Aging Neurosci. 2022 Jul 4;14:925855. doi: 10.3389/fnagi.2022.925855. eCollection 2022.
8
Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota.尿石素:代谢、生物活性及其相关肠道微生物组的综合更新。
Mol Nutr Food Res. 2022 Nov;66(21):e2101019. doi: 10.1002/mnfr.202101019. Epub 2022 Feb 15.